Navigation Links
A New Interactive Consumer Experience Highlighting Successful Weight Loss Strategies is Coming to a Mall Near You

GlaxoSmithKline Consumer Healthcare Launches Nationwide "alli Experience(R)" Mall Tour to Help Americans Make Informed and Healthier

Eating Decisions

PITTSBURGH, Sept. 21 /PRNewswire-FirstCall/ -- Today, GlaxoSmithKline Consumer Healthcare (NYSE: GSK) announces the launch of the "alli Experience" mall tour. The "alli Experience" mall tour will stop in 12 major U.S. cities to educate overweight adults on healthy weight loss strategies as well as introduce them to the alli program.

Launched in June 2007, alli (orlistat 60 mg) is the only FDA-approved weight-loss product available to overweight adults without a prescription. It is the first clinically-proven over-the-counter weight loss product to be combined with a comprehensive support program ( The "alli Experience" tour will speak to current alli users, consumers considering the product and those who tried the program and decided they weren't ready to commit.

"Based on consumers' positive feedback of the 'alli Experience,' the initial installation in New York City earlier this year where over 10,000 people visited in 19 days, we have decided to continue the momentum and take that unique experience to others across the U.S." says Steven L. Burton, vice president, Weight Control, GlaxoSmithKline Consumer Healthcare. "We want to make sure as many people as possible have a chance to experience this unique educational exhibit which will provide them with extremely useful information on the alli program so they can make a fully-informed decision whether they are ready to commit to trying alli. We chose to take the alli Experience to malls across the country as the environment provides a perfect setting for us to talk to consumers in a place that's convenient and comfortable."

The "alli Experience" mall tour is designed to help overweight adults adopt the principles of modest, gradual weight loss. The multi-media exhibit, divided into 3 zones, encourages visitors to embrace a more realistic approach to diet and exercise for improved health. The exhibit will also help overweight people who want to lose weight determine if they are ready to commit to trying alli.

-- Zone 1 ("You"): In this area visitors can learn about empowerment and

how to take the first step towards weight loss.

-- Zone 2 ("Food"): Visitors are then greeted by a registered dietician

who can provide tips for healthy eating and strategies for safe weight


-- Zone 3 ("alli"): In the final zone consumers learn more about the

product through a number of interactive stations. This area helps

visitors find out if they are ready for a true weight loss commitment

or still hoping for a quick fix. They can ask a pharmacist questions

about taking alli while on other medications. They can also

learn how alli can help them lose 50 percent more weight than dieting


The "alli Experience" mall tour will take place from September 21 through November 18, 2007 stopping in popular malls in Atlanta (North Point Mall), Chicago (Northbrook Court), Dallas (Stonebriar Centre), Detroit (Lakeside Mall), Houston (Houston Galleria), Los Angeles (Glendale Galleria), Minneapolis (Mall of America), Long Island, NY (Roosevelt Field), Philadelphia (King of Prussia Mall), St. Louis (Saint Louis Galleria), San Jose (Valley Fair) and Washington, DC (Tysons Galleria). The "alli Experience" exhibit is free of charge and will be open daily (12:00pm to 7:00pm Monday through Saturday; 11:00am to 6:00pm on Sunday). Teenagers and children unaccompanied by an adult will not be allowed entrance into the exhibit.

Consumers visiting the alli Experience will take away educational information and tools such as brochures, recipes and meal planners to help support the alli program. Those who cannot attend the exhibit can experience it online by visiting

alli is currently available in pharmacies and mass retailers nationwide. For more information about alli and the alli program, go to Information on alli and the alli program are also available in Spanish at

About alli(R) Weight Loss Aid

alli (orlistat 60mg), the only FDA-approved weight-loss product available to overweight adults without a prescription, combines a clinically-proven product with a comprehensive individualized action plan. The alli program encourages modest, gradual weight loss, known by experts as the best way to lose weight. alli is to be taken three times a day with meals containing fat and has been available in pharmacies and mass retailers nationwide since June 15, 2007.

About GlaxoSmithKline Consumer Healthcare

GSK Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette(R), NicoDerm(R) CQ and Commit(R) as well as many medicine cabinet staples, including Abreva(R), Aquafresh(R), Sensodyne,(R) Tums(R) and Breathe Right(R).

About GlaxoSmithKline

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit:

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Interactive Video, Better Teaching Aid For Toddlers
2. Interactive Digital Television to Monitor Health
3. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
4. Iodex goes to SmithKline Beecham consumer Healthcare
5. Consumer group seeks Sibutramine ban
6. Identifying What Consumers Look For On Food Stuff Labels
7. Consumers Becoming More Health Conscious Than Calorie Conscious
8. With More Appearance Conscious Consumers The Need For Slimming Products Is Rapidly Rising
9. Consumers of soft drinks to be more alert
10. Consumers Worried About Trans-Fats The Most
11. New Plastic Surgery Unit Set Up In Kolkata To Meet Ever-Increasing Consumer Demand
Post Your Comments:
(Date:11/28/2015)... ... , ... Safe storage for contraceptive devices may not always be easy to ... and the other from Bradley Beach, New Jersey, there is an easy solution to ... to replace NuvaRings more often than necessary. As such, it affords peace of mind ...
(Date:11/27/2015)... Canada (PRWEB) , ... November 28, 2015 , ... There ... do we outperform our billings from last year? , This question has not been ... organizations are coming to the retirement age and the younger workforce don’t share the ...
(Date:11/27/2015)... ... 2015 , ... The rapid speed at which Americans are ... care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming more ... forgotten part of this equation: 80 percent of medical care occurs in the ...
(Date:11/27/2015)... County, CA (PRWEB) , ... November 27, 2015 , ... ... season , The company is offering customers 10% off of their purchase of lice ... any treatment at full price. According to a company spokesperson. “Finding lice is a ...
(Date:11/27/2015)... ... November 27, 2015 , ... Consistent ... sharing, the 2016 Building Better Radiology Marketing Programs meeting will showcase ... Sunday, March 6, 2016, at Caesars Palace in Las Vegas with a pre-conference ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
(Date:11/25/2015)... WOODBURY, N.Y. , Nov. 25, 2015  Linden ... access and optimizing treatment outcomes for patients suffering from ... its request for a Temporary Restraining Order (TRO) enjoining ... between the two companies. --> ... aggressively pursuing all of its legal options. ...
(Date:11/25/2015)... -- On Tuesday, November 24, 2015, the jury ... Medical Technology, Inc. for product liability and misrepresentation ... device, awarded $11 million in favor of Plaintiff ... three days of deliberations, the jury found that ... and unreasonably dangerous, and that Wright Medical made ...
Breaking Medicine Technology: